Zentek Ltd - ZENYF stock
OTC Symbol: ZENYF | Related ticker symbols: Zentek is currently listed on the NASDAQ exchange
Zentek was listed and began trading on NASDAQ effective March 22, 2022 under the ticker symbol ZTEK.[1] OTC Wiki congratulates Zentek on this major accomplishment!
About Zentek Ltd[edit]
Zentek Ltd (OTC: ZENYF) was earlier known as Zenyatta Ventures and ZEN Graphene Solutions, a minerals investigation firm established in Ontario, Canada, on July 29, 2008. The company is one of the patent turns of events and commercialization businesses that utilize nano material's ability to separate atomic science limits and uncover new choices in medical care.
Also, they have tremendous worth through forthcoming clinical administrations and then some, with practically endless potential to work on individuals' lives. Zentek is working at the Albany Graphite Deposit, a unique aqueous graphite store that creates regular, high-virtue graphite with c enterprises recently overwhelmed by engineered graphite.[2]
Zentek high crystallinity graphite can be upgraded without harsh corrosives or high-temperature warm treatment. They developed a harmless metallurgy process flowsheet incorporating crushing, buoyancy, and sodium hydroxide burning therapy.
The company utilizes composites (concrete, elastic, and plastics), energy capacity, and natural applications for graphene materials.[3]
Products of Zentek Ltd.[edit]
- Graphene-based antimicrobial coatings
- Surgical masks
- HVAC filters
- Personal protective equipment
- Graphene, graphene oxide, and graphene nanocrystals for graphene applications
Zentek's Innovative Technologies[edit]
ZenGUARDTM innovation works on the adequacy of air filtration media utilized in HVAC frameworks. This innovation channels and deactivates infections to restrict the gamble of transmission, making inside regions, high-risk work circumstances, and social communications more secure. ZenGUARDTM has water-drawing in hydrophilic covering that absorbs bacteria and infection-loaded sprayers and deactivates them, supporting public security and bringing down the gamble of COVID and other microorganism transmissions.
Zentek's Aptamer Technology is patent-forthcoming graphene-based detailing that has demonstrated to be protected and compelling in treating human-contracted infections and overseeing irresistible diseases. This new aptamer is designed to recognize different microbes, increasing security and engaging enterprises and medical care providers outside COVID.
Broad-Spectrum Effectiveness of Zentek[edit]
Zentek's graphene-based plan has exhibited outstanding security in revolutionizing treating human-contracted contaminations and infections. During the cytotoxicity tests, they focused on demonstrating that their substance was effective in treating microbes, diseases, and growth. Their target areas were stomach-related and respiratory frameworks, eyes, ears, and skin regions.
Zentek in Fighting a Global Threat[edit]
Zentek is currently pursuing preliminary preclinical research and is working with research associations and government companies to introduce graphene-based chemicals to the public as quickly as possible. The company believes in the expansive range and antimicrobial medications expected to battle the worldwide risk. Nanotechnology and graphene-based substance assume an indispensable part.[4]
As indicated by ZEN ltd, the company has concluded that NeoVentures Biotechnology Inc., a world innovator in aptamer improvement and applications with McMaster results against spike proteins, is effectively improving and working on the innovation in anticipation and business creation. ZEN and NeoVentures further foster a model to develop discovery impediments and responsiveness.
ZEN hired axiVEND, a biosensor advancement on the computerized course of producing sensors on aptamers. The company has fostered an upgraded aptamer with a superior restricting proclivity for the COVID-19 Delta variation in a joint effort with expected accomplices and McMaster.[5]
Investing in Zentek[edit]
Zentek is an innovator in the turn of events and commercialization of cutting-edge nanotechnology-empowered medical services that work on individuals' lives. Putting resources into the Zentek company is a versatile, unique open door, and the company points to prevention, detection, and treatment as critical differentiators.[6]
